EN PL
REVIEW PAPER
Radionuclide synovectomy – essentials for rheumatologists
 
More details
Hide details
 
Submission date: 2016-03-07
 
 
Final revision date: 2016-05-28
 
 
Acceptance date: 2016-05-30
 
 
Online publication date: 2016-07-18
 
 
Publication date: 2016-06-30
 
 
Reumatologia 2016;54(3):108-116
 
KEYWORDS
TOPICS
ABSTRACT
Radionuclide synovectomy is a minimally invasive method of treating persistent joint inflammation. It involves intra-articular injection of radioactive colloids which induce necrosis and fibrosis of hypertrophic synovial membrane. The most common indication for radiosynovectomy is rheumatoid arthritis, although patients with seronegative spondyloarthropathies, unclassified arthritis, haemophilic arthropathy and other less common arthropathies can also benefit from this method. Radiosynovectomy is safe, well tolerated and efficacious. About 70–80% of patients respond well to the therapy. However, the therapeutic effects are considerably worse in patients with co-existent osteoarthritis and advanced joint degeneration. Despite its advantages, radionuclide synovectomy is not performed as often as it could be, so greater knowledge and understanding of this method are needed. The authors present the most important facts about radiosynovectomy that may help rheumatologists in their daily clinical practice.
 
REFERENCES (36)
1.
Schneider P, Farahati J, Reiners C. Radiosynovectomy in rheumatology, orthopedics, and hemophilia. J Nucl Med 2005; 46 Suppl 1: 48S-54S.
 
2.
Ishido C. Über die Wirkung des Radiothoriums auf die Gelenke. Strahlentherapie 1924; 15: 537-544.
 
3.
Ansell BM, Crook A, Mallard JR, et al. Evaluation of intra-articular colloidal gold Au 198 in the treatment of persistent knee effusions. Ann Rheum Dis 1963; 22: 435-439.
 
4.
Bowen BM, Darracott J, Garnett ES, et al. Yttrium-90 citrate colloid for radioisotope synovectomy. Am J Hosp Pharm 1975; 32: 1027-1030.
 
5.
Savio E, Ures MC, Zeledón P, et al. 188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates. BMC Nucl Med 2004; 4: 1.
 
6.
Ex: Modder G, Radionuclide Therapy of Inflammatory Joint Diseases (Radiation Synovectomy, Radiosynoviorthesis). In: Baum RP. Therapeutic Nuclear Medicine. Springer, Heidelberg, New York, Dordrecht, London 2014: 459-492.
 
7.
Uğur O, Gedik GK, Atilla B, et al. Radiosynovectomy: current status in the management of arthritic conditions. Nucl Med Commun 2008; 29: 755-758.
 
8.
Turkmen C. Safety of radiosynovectomy in hemophilic synovitis: it is time to re-evaluate. J Coagul Dis 2009; 1: 1-8.
 
9.
Heuft-Dorenbosch LL, de Vet HC, van der Linden S. Yttrium radiosynoviorthesis in the treatment of knee arthritis in rheumatoid arthritis: a systematic review. Ann Rheum Dis 2000; 59: 583-586.
 
10.
Berliner MN, Bretzel RG, Klett R. Successful radiosynoviorthesis of an olecranon bursitis in psoriatic arthritis. Ann Rheum Dis 2002; 61: 187-188.
 
11.
Kröger S, Sawula JA, Klutmann S. Effect of radiosynovectomy in patients with inflammatory joint disorders not caused by rheumatoid arthritis. Nuklearmedizin 1999; 38: 279-284.
 
12.
Clunie G, Fischer M; EANM. EANM Procedure Guidelines for Radiosynovectomy. Eur J Nucl Med Mol Imaging 2003; 30:.
 
13.
12-16.
 
14.
Sosna A, Radonský T, Pokorný D, et al. Polyethylene disease. Acta Chir Orthop Traumatol Cech 2003; 70: 6-16.
 
15.
Rampersad AG, Shapiro AD, Rodriguez-Merchan EC. Radiosynovectomy: review of the literature and report from two haemophilia treatment centers. Blood Coagul Fibrinolysis 2013; 24: 465-470.
 
16.
Knut L. Radiosynovectomy in the Therapeutic Management of Arthritis. World J Nucl Med 2015; 14: 10-15.
 
17.
Obwieszczenie ministra zdrowia z dnia 6 listopada 2013 r. w sprawie ogłoszenia wykazu wzorcowych procedur radiologicznych z zakresu medycyny nuklearnej. Dziennik Urzędowy Ministra Zdrowia, Warszawa 2013 r., poz. 45.
 
18.
Wong Y, Cherk MH, Powell A, et al. Efficacy of yttrium-90 synovectomy across a spectrum of arthropathies in an era of improved disease modifying drugs and treatment protocols. Int J Rheum Dis 2014; 17: 78-83.
 
19.
Teh J, Stevens K, Williamson L, et al. Power Doppler ultrasound of rheumatoid synovitis: quantification of therapeutic response. Br J Radiol 2003; 76: 875-879.
 
20.
Walczyk M, Wysocki T, Olesińska M. Thrombosis prophylaxis in patients with inflammatory rheumatic diseases. Reumatol Geriatr Rehabil 2015; 1: 25-33.
 
21.
Manafi Rasi A, Kazemian G, Emami Moghadam M, et al. Deep vein thrombosis following below knee immobilization: the need for chemoprophylaxis. Trauma Mon 2013; 17: 367-369.
 
22.
Guillen Astete CA, Bouroncle Alaluna C, Boteanu A, et al. Safety of Joint Puncture in Patients Anticoagulated with Acenocumarol. Ann Rheum Dis 2014; 73: 1115-1116.
 
23.
Ćwikła B, Żbikowski P, Kwiatkowska B. Radiosynovectomy in rheumatic diseases. J Ultrason 2014; 14: 241-251.
 
24.
Chojnowski MM, Kobylecka M, Płazińska MT, et al. Popliteal cyst after yttrium-90 radiosynovectomy-usefulness of delayed PET/CT imaging. Rheumatology (Oxford) 2014; 53: 1983.
 
25.
Ex: Modder G. Radiosynoviorthesis. Meckenheim: Warlich Druck und Verlagsges, 2001: 31-49.
 
26.
Kresnik E, Mikosch P, Gallowitsch HJ, et al. Clinical outcome of radiosynoviorthesis: A meta-analysis including 2190 treated joints. Nucl Med Commun 2002; 23: 683-688.
 
27.
Liepe K. Efficacy of radiosynovectomy in rheumatoid arthritis. Rheumatol Int 2012; 32: 3219-3224.
 
28.
Kisielinski K, Bremer D, Knutsen A, et al. Complications following radiosynoviorthesis in osteoarthritis and arthroplasty: osteonecrosis and intra-articular infection. Joint Bone Spine 2010; 77: 252-257.
 
29.
Oztürk H, Oztemür Z, Bulut O. Treatment of skin necrosis after radiation synovectomy with yttrium-90: a case report. Rheumatol Int 2008; 28: 1067-1068.
 
30.
Voth M, Klett R, Lengsfeld P. Biological dosimetry after Yttrium-90 citrate colloid radiosynoviorthesis (RSO). Nuklearmedizin 2006; 45: 223-228.
 
31.
Infante-Rivard C, Rivard GE, Derome F, et al. A retrospective cohort study of cancer incidence among patients treated with radiosynoviorthesis. Haemophilia 2012; 18: 805-809.
 
32.
Turkmen C, Ozturk S, Unal SN, et al. The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid. Cancer Biother Radiopharm 2007; 22: 393-399.
 
33.
Klett R, Puille M, Matter HP, et al. Activity leakage and radiation exposure in radiation synovectomy of the knee: Influence of different therapeutic modalities. Z Rheumatol 1999; 58: 207-212.
 
34.
Modder G. Radiosynoviorthesis. Warlich Druck und Verlagsges, Meckenheim 2001: 82-83.
 
35.
Mäkelä OT, Lammi MJ, Uusitalo H, et al. Analysis of lapine cartilage matrix after radiosynovectomy with holmium-166 ferric hydroxide macroaggregate. Ann Rheum Dis 2003; 62: 43-49.
 
36.
Delbarre F, Cayal J, Menkes C. La synoviorthese par les radio-isotopes. Presse Med 1968; 76: 1045-1050.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top